-
-
-
-
-
-
-
Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance
-
-
-
-
-
-
-
Tarsus Pharmaceuticals, Inc. (TARS) Tops Q3 EPS by 5c
-
-
-
-
-
-
-
Tarsus Pharmaceuticals (TARS) PT Raised to $58 at Jefferies
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
-
-
-
435,450 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

